ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
First RXC006 data suggests it has great potential for the treatment of fibrosis
December 02, 2018In the first public disclosure of data on RXC006, Dr Peter Bunyard, Head of Fibrosis at Redx, presented results from preclinical studies in a plenary session as well as a poster which showed that RXC006 was highly effective at suppressing the Wnt pathway
Pharma Sources Insight January 2025
